FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know

Published Jul 28, 2021

FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know

The Food and Drug Administration (FDA) has just approved a new treatment option for women with advanced uterine cancer. The combination of immunotherapy drugs Keytruda and Lenvima for the disease after initial treatment has failed. Here's what to know.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.